BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6296358)

  • 1. Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Feb; 224(2):359-63. PubMed ID: 6296358
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative involvement of receptor subtypes in opioid-induced inhibition of intestinal motility in mice.
    Ward SJ; Takemori AE
    Life Sci; 1982 Sep 20-27; 31(12-13):1267-70. PubMed ID: 6128653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F; Burks TF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat.
    Porreca F; Raffa RB; Cowan A; Tallarida RJ
    Life Sci; 1982 Nov; 31(18):1955-61. PubMed ID: 6294424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
    Thor KB; Hisamitsu T; Roppolo JR; Tuttle P; Nagel J; deGroat WC
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1018-25. PubMed ID: 2539452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
    Portoghese PS; Lipkowski AW; Takemori AE
    Life Sci; 1987 Mar; 40(13):1287-92. PubMed ID: 2882399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists.
    Ben-Sreti MM; Sewell RD
    J Pharm Pharmacol; 1982 Aug; 34(8):501-5. PubMed ID: 6126560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine.
    Portoghese PS; Nagase H; Takemori AE
    J Med Chem; 1988 Jul; 31(7):1344-7. PubMed ID: 2838632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonists at the opiate delta-receptor.
    Shaw JS; Miller L; Turnbull MJ; Gormley JJ; Morley JS
    Life Sci; 1982 Sep 20-27; 31(12-13):1259-62. PubMed ID: 6128652
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1987 Jun; 30(6):1040-4. PubMed ID: 3035177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered opiate receptor binding in synaptosomes: implication of phosphorylation.
    Stokes KB; Loh HH
    Proc West Pharmacol Soc; 1984; 27():423-7. PubMed ID: 6093135
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.
    Yoburn BC; Luke MC; Pasternak GW; Inturrisi CE
    Life Sci; 1988; 43(16):1319-24. PubMed ID: 2845219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of piracetam on the effects of narcotic analgesics].
    Chichenkov ON; Krylova IN; Borozdin MIu; Pokatilov DV
    Farmakol Toksikol; 1990; 53(2):22-4. PubMed ID: 1973390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ; Holtzman SG
    Eur J Pharmacol; 1980 Nov; 68(1):1-10. PubMed ID: 6256182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
    Kumor KM; Haertzen CA; Johnson RE; Kocher T; Jasinski D
    J Pharmacol Exp Ther; 1986 Sep; 238(3):960-8. PubMed ID: 3018228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
    Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of kappa agonist.
    Kumor K; Su TP; Vaupel B; Haertzen C; Johnson RE; Goldberg S
    NIDA Res Monogr; 1986; 67():18-25. PubMed ID: 3018572
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differences in opioid binding in the left and right visual cortex of the turtle].
    Kobylianskiĭ AG; Pivovarov AS; Nesterenko PN; Iarygin KN; Bakalkin GIa
    Dokl Akad Nauk SSSR; 1986; 291(2):479-83. PubMed ID: 3024944
    [No Abstract]   [Full Text] [Related]  

  • 20. Different modes of opiate interaction in rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1683-6. PubMed ID: 6759825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.